Harpoon Therapeutics stock trades on limited verified market data
Published on 09/23/2026 at 03:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Harpoon Therapeutics, Inc. (US4135961044) is identified as a biotechnology company, with the stock reference anchored to the September 23, 2026 publication date. The available market record provides the company identity and ISIN but does not establish a dated exchange quotation.
Identity remains the key fact
Harpoon Therapeutics is associated with biotechnology research and development. The ISIN US4135961044 is the central security identifier for the requested stock article, while the company name and identifier are consistent with the target entity.
Reported figures need period labels
Fundamental figures such as revenue, earnings, margins, guidance and cash flow require a clearly named reporting period before they can be treated as current. No such period-specific figure is included in the available record for September 23, 2026.
Security record for September 23
The dated market value used here is the ISIN record for US4135961044 as of September 23, 2026. A current exchange price, daily percentage change, market capitalization, volume and 52-week range are not included in the available market record.
Harpoon Therapeutics security data
- Company: Harpoon Therapeutics, Inc.
- ISIN: US4135961044
- Sector / Industry: Biotechnology
